InvestorsHub Logo
Followers 34
Posts 3564
Boards Moderated 0
Alias Born 11/17/2013

Re: newman2021 post# 474924

Tuesday, 05/17/2022 4:11:22 PM

Tuesday, May 17, 2022 4:11:22 PM

Post# of 705558
I sent AACR the following hardnosed email:

AACR
Attention Margaret Foti
615 Chestnut St., 17th Floor
Philadelphia, PA 19106-4404 USA
Telephone: 215-440-9300
Email: aacr@aacr.org

ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) and the American Association for Cancer Research (AACR) announce today their 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research program. The program represents a joint effort to promote and support innovative research on Tumor Treating Fields to help deepen the understanding of the mechanism of action and to accelerate the development of new treatment strategies. The program includes research grants and career development awards totaling more than $2 million over the next three years.

“Our partnership with Novocure continues to break new ground toward the advancement of cancer science,” said Mitch Stoller, Chief Philanthropic Officer and Vice President of Development of the AACR Foundation. “We are grateful for Novocure’s visionary support of the AACR’s Grants Program, and we look forward to witnessing the innovative research that will result from these important grants.”

Well, now we know whose pocket the AACR is in! Is this why the AACR closed their eyes and reported very misleadingly, and knowingly a very false picture of the news in the NYAS presentation by NWBO!! How much money came from Novocure, that it was worth harming your reputation. Shame!

If they do retract and correct their reporting of the NYAS presentation I will then consider reviewing my shattered opinion of them. We'll see if the AACR retracts their article after the NWBO endpoints are modified in the clinicaltrials website..

When DCVAX-L becomes the SOC for GBM and moves on to treatment of solid tumors, and NWBO becomes a biopharma powerhouse, NWBO should well remember the biased treachery of the AACR!

I find it highly troubling that such an old and venerable institution can stoop as low as they did and misinform (LIE) about the outcome of the trial. They are not stupid and they fully understand how they misrepresented the results of the NYAS presentation. They should never get a dime from anyone in the future. They are not worthy of the trust put in them.

I hope you redeem your reputation ASAP be a LOUD and CLEAR retraction of your story on the NYAS NWBO presentation! Do not tarry.

Sincerely,
................
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News